Tenon Medical, Inc. TNON
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 126.77% | 89.94% | 92.34% | 32.24% | -37.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 126.77% | 89.94% | 92.34% | 32.24% | -37.40% |
| Cost of Revenue | 45.77% | 7.69% | 11.27% | -14.71% | -25.99% |
| Gross Profit | 232.24% | 192.57% | 188.10% | 84.93% | -47.87% |
| SG&A Expenses | 30.82% | 7.68% | 13.49% | -0.60% | -28.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.43% | 5.81% | 10.25% | -7.70% | -28.33% |
| Operating Income | -17.40% | 10.80% | 9.68% | 18.72% | 26.21% |
| Income Before Tax | -46.26% | 3.87% | 8.26% | -4.87% | 27.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.26% | 3.87% | 8.26% | -4.87% | 27.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.26% | 3.87% | 8.26% | -4.87% | 27.63% |
| EBIT | -17.40% | 10.80% | 9.68% | 18.72% | 26.21% |
| EBITDA | -17.27% | 12.19% | 9.16% | 18.54% | 25.75% |
| EPS Basic | 3.24% | 69.31% | 70.50% | 88.85% | 95.53% |
| Normalized Basic EPS | 3.24% | 69.31% | 70.50% | 91.45% | 95.53% |
| EPS Diluted | 3.24% | 69.31% | 70.50% | 88.85% | 95.53% |
| Normalized Diluted EPS | 3.24% | 69.31% | 70.50% | 91.45% | 95.53% |
| Average Basic Shares Outstanding | 51.15% | 213.13% | 210.89% | 839.04% | 1,519.40% |
| Average Diluted Shares Outstanding | 51.15% | 213.13% | 210.89% | 839.04% | 1,519.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |